Objective
To provide Shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies.
Management group
Bellevue Asset Management
Launch date
02/12/2016
Domicile
United Kingdom
Fund manager
Paul Major, Brett Darke
Dividend frequency
Semi-Annually
Wind-up provisions
There are no specific provisions for the termination of the life of the Company.
Market Cap (m) Total assets (m) Price (last close) NAV Discount / premium (%) Gearing (%) Dividend yield (%) Dividend dates Ongoing charge (%)
652.75 719.36 141.20 152.20 -7.23 0 3.57 Feb, Jul 1.02 (30/11/2023)
Scroll

Dividends

Dividends declared in last 12 months

Ex-Dividend date Payment date Dividend amount Special dividend Financial year
09/05/2024 31/05/2024 2.995 No 2023
27/07/2023 25/08/2023 2.995 No 2023
Scroll

Performance (%)

Return type 1 year 3 years 5 years 10 years
Bellevue Healthcare Trust Share price total return -5.4 -13.5 20.8 N/A
Biotechnology & Healthcare AIC sector Share price total return -3.1 -15.8 5.3 129.0
Scroll

Share structure

Number of shares
462,288,550

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 3,217,991 42,035,106 333,027,898 1,360,224,904
Average N/A 2,055,450 1,320,670 1,079,660
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 4.54 60.46 481.34 2,186.00
Average N/A 2.95 1.91 1.73
Scroll

Trading details

ISIN TIDM Traded currency Stock exchange
GB00BZCNLL95 BBH GBX London Stock Exchange - MAIN
Chi-x Europe Limited
London Stock Exchange
Scroll

Top holdings

Data as at : 30/11/2023

Investment % of total assets
Option Care Health Inc 6.9
Insmed Inc 6.9
Axonics Inc 6.9
Evolent Health Inc Class A 6.6
Exact Sciences Corp 6.4
Intuitive Surgical Inc 5.2
Pacific Biosciences of California Inc 5.1
Apellis Pharmaceuticals Inc 4.8
Bio-Rad Laboratories Inc Class A 4.8
Charles River Laboratories International Inc 4.8

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.